Showing 1 - 8 results of 8 for search 'Can Yurttas', query time: 0.03s
Refine Results
-
1
Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors by Philipp Horvath, Can Yurttas, Stefan Beckert, Alfred Königsrainer, Ingmar Königsrainer
Published 2021-05-01
Article -
2
-
3
Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference... by Miklos Acs, Michael Gerken, Vanessa Schmitt, Pompiliu Piso, Alfred Königsrainer, Saher Baransi, Can Yurttas, Sebastian Häusler, Philipp Horvath
Published 2023-01-01
Article -
4
Current Medical Care Situation of Patients in Germany Undergoing Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) by Philipp Horvath, Can Yurttas, Isabella Baur, Christoph Steidle, Marc André Reymond, Paolo Nicola Camillo Girotti, Alfred Königsrainer, Ingmar Königsrainer
Published 2022-03-01
Article -
5
Retrospective analysis of different therapeutic approaches for retroperitoneal duodenal perforations by Can Yurttas, Christian Thiel, Dörte Wichmann, Philipp Horvath, Jens Strohäker, Malte Niklas Bongers, Martin Schenk, Dietmar Stüker, Alfred Königsrainer, Karolin Thiel
Published 2022-06-01
Article -
6
Endoscopic negative pressure therapy as stand-alone treatment for perforated duodenal diverticulum: presentation of two cases by Dörte Wichmann, Kai Tobias Jansen, Flurina Onken, Dietmar Stüker, Emanuel Zerabruck, Christoph R. Werner, Can Yurttas, Karolin Thiel, Alfred Königsrainer, Markus Quante
Published 2021-11-01
Article -
7
Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma by Can Yurttas, Julia Beil, Susanne Berchtold, Irina Smirnow, Linus D. Kloker, Bence Sipos, Markus W. Löffler, Alfred Königsrainer, André L. Mihaljevic, Ulrich M. Lauer, Karolin Thiel
Published 2024-01-01
Article -
8
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model by Nick Seyfried, Can Yurttas, Markus Burkard, Benedikt Oswald, Alexander Tolios, Franziska Herster, Joseph Kauer, Tarkan Jäger, Ingmar Königsrainer, Karolin Thiel, Markus Quante, Hans-Georg Rammensee, Sascha Venturelli, Matthias Schwab, Alfred Königsrainer, Stefan Beckert, Markus W. Löffler
Published 2022-02-01
Article